SZ011

· Shantou University Medical College

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SZ011, covering 2024-08-13 to 2024-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma [EARLY_Phase 1]